IFNA2 and psoriasis: They also demonstrated that the skin lesions caused by TNF-α inhibitor-induced psoriasis are characterized by the dermal accumulation of pDCs and that TNF-α blockade prolongs the ability of pDCs to produce IFN-α by inhibiting their maturation, which results in type I IFN overexpression [47].